264 related articles for article (PubMed ID: 22348200)
1. PI3K and STAT3: a new alliance.
Vogt PK; Hart JR
Cancer Discov; 2011 Nov; 1(6):481-6. PubMed ID: 22348200
[TBL] [Abstract][Full Text] [Related]
2. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
[TBL] [Abstract][Full Text] [Related]
3. Essential role of Stat3 in PI3K-induced oncogenic transformation.
Hart JR; Liao L; Yates JR; Vogt PK
Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13247-52. PubMed ID: 21788516
[TBL] [Abstract][Full Text] [Related]
4. BMX/Etk promotes cell proliferation and tumorigenicity of cervical cancer cells through PI3K/AKT/mTOR and STAT3 pathways.
Li Y; Cui N; Zheng PS; Yang WT
Oncotarget; 2017 Jul; 8(30):49238-49252. PubMed ID: 28514765
[TBL] [Abstract][Full Text] [Related]
5. HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling.
Ke B; Shen XD; Ji H; Kamo N; Gao F; Freitas MC; Busuttil RW; Kupiec-Weglinski JW
J Hepatol; 2012 Feb; 56(2):359-66. PubMed ID: 21756853
[TBL] [Abstract][Full Text] [Related]
6. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3.
Gu FM; Li QL; Gao Q; Jiang JH; Huang XY; Pan JF; Fan J; Zhou J
World J Gastroenterol; 2011 Sep; 17(34):3922-32. PubMed ID: 22025881
[TBL] [Abstract][Full Text] [Related]
8. Regulating RISK: a role for JAK-STAT signaling in postconditioning?
Goodman MD; Koch SE; Fuller-Bicer GA; Butler KL
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1649-56. PubMed ID: 18708442
[TBL] [Abstract][Full Text] [Related]
9. STAT3 activation in pressure-overloaded feline myocardium: role for integrins and the tyrosine kinase BMX.
Willey CD; Palanisamy AP; Johnston RK; Mani SK; Shiraishi H; Tuxworth WJ; Zile MR; Balasubramanian S; Kuppuswamy D
Int J Biol Sci; 2008 Jun; 4(3):184-99. PubMed ID: 18612371
[TBL] [Abstract][Full Text] [Related]
10. NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations.
Park E; Park J; Han SW; Im SA; Kim TY; Oh DY; Bang YJ
Int J Oncol; 2012 Apr; 40(4):1259-66. PubMed ID: 22159814
[TBL] [Abstract][Full Text] [Related]
11. The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cdelta.
Saharinen P; Ekman N; Sarvas K; Parker P; Alitalo K; Silvennoinen O
Blood; 1997 Dec; 90(11):4341-53. PubMed ID: 9373245
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.
Incrocci R; Barse L; Stone A; Vagvala S; Montesano M; Subramaniam V; Swanson-Mungerson M
Virology; 2017 Jan; 500():96-102. PubMed ID: 27792904
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
14. Src family kinases mediate receptor-stimulated, phosphoinositide 3-kinase-dependent, tyrosine phosphorylation of dual adaptor for phosphotyrosine and 3-phosphoinositides-1 in endothelial and B cell lines.
Stephens LR; Anderson KE; Hawkins PT
J Biol Chem; 2001 Nov; 276(46):42767-73. PubMed ID: 11524430
[TBL] [Abstract][Full Text] [Related]
15. STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.
Wu C; Molavi O; Zhang H; Gupta N; Alshareef A; Bone KM; Gopal K; Wu F; Lewis JT; Douglas DN; Kneteman NM; Lai R
Blood; 2015 Jul; 126(3):336-45. PubMed ID: 25921060
[TBL] [Abstract][Full Text] [Related]
16. Neoplastic transformation by the gep oncogene, Galpha12, involves signaling by STAT3.
Kumar RN; Shore SK; Dhanasekaran N
Oncogene; 2006 Feb; 25(6):899-906. PubMed ID: 16247467
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.
Han SS; Yun H; Son DJ; Tompkins VS; Peng L; Chung ST; Kim JS; Park ES; Janz S
Mol Cancer; 2010 Apr; 9():97. PubMed ID: 20433747
[TBL] [Abstract][Full Text] [Related]
18. Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance.
Shi Y; Guryanova OA; Zhou W; Liu C; Huang Z; Fang X; Wang X; Chen C; Wu Q; He Z; Wang W; Zhang W; Jiang T; Liu Q; Chen Y; Wang W; Wu J; Kim L; Gimple RC; Feng H; Kung HF; Yu JS; Rich JN; Ping YF; Bian XW; Bao S
Sci Transl Med; 2018 May; 10(443):. PubMed ID: 29848664
[TBL] [Abstract][Full Text] [Related]
19. Targeting PI3K in cancer: mechanisms and advances in clinical trials.
Yang J; Nie J; Ma X; Wei Y; Peng Y; Wei X
Mol Cancer; 2019 Feb; 18(1):26. PubMed ID: 30782187
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 mediates resistance to PI3K-pathway-targeted therapy in lymphoma.
Kim JH; Kim WS; Park C
BMC Cancer; 2019 Oct; 19(1):936. PubMed ID: 31601188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
